{
    "2018-01-30": [
        [
            {
                "time": "",
                "original_text": "智飞生物高估值背后：资金押注公司疫苗研发潜力？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "高估值",
                        "疫苗",
                        "研发潜力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大股东欲减持近亿股 多家券商热捧的智飞生物“两连跌”",
                "features": {
                    "keywords": [
                        "大股东",
                        "减持",
                        "智飞生物",
                        "券商",
                        "两连跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药行业周报：政策持续推动行业整合 重点关药品及服务板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策",
                        "行业整合",
                        "药品",
                        "服务板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药行业周报：把握结构性机会 重点关注创新和高端仿制",
                "features": {
                    "keywords": [
                        "医药行业",
                        "结构性机会",
                        "创新",
                        "高端仿制"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "沪深上市公司18年1月29日晚间上市公司重要公告",
                "features": {
                    "keywords": [
                        "沪深上市公司",
                        "公告"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}